Literature DB >> 28947262

Perfluorooctanoic acid exposure disturbs glucose metabolism in mouse liver.

Fei Zheng1, Nan Sheng2, Hongxia Zhang2, Shengmin Yan2, Jianhai Zhang3, Jianshe Wang4.   

Abstract

Environmental pollutants such as perfluorooctanoic acid (PFOA) can influence human metabolism processes and are associated with certain metabolic diseases. To investigate the effect of PFOA on liver glucose homeostasis, adult male Balb/c mice were orally administered 1.25mg/kg of PFOA for 28d consecutively. Compared with the control mice, the body weights of the PFOA-treated mice were unchanged following exposure. However, PFOA exposure increased fasting blood glucose levels and decreased glycogen and glucose content in the liver of treated mice, but did not influence blood insulin significantly. The increased blood glucagon might contribute to the hyperglycemia observed in the PFOA-treated group compared with the control group. In addition, pyruvate tolerance tests supported enhanced glucose production ability in PFOA-exposed mice. Consistent with the increase in blood glucose and decrease in hepatic glucose and glycogen, PFOA exposure decreased the protein level of glycogen synthase in the mouse liver, but increased the level of glucokinase. Furthermore, liver pyruvate, as well as mRNA levels of enzymes involved in the Krebs cycle, such as citrate synthase, isocitrate dehydrogenase, and alpha-ketoglutarate dehydrogenase, increased in the PFOA-treated group. PFOA exposure did not affect muscle glucose or glycogen levels. Indirect calorimetry showed higher VO2 consumption and respiratory quotient values in the PFOA-treated group compared with the control group, implying that PFOA treatment might promote energy consumption in mice, with a reliance on carbohydrates as a primary source of energy. Thus, our findings indicate that subacute exposure to PFOA might enhance glycogenolysis and gluconeogenesis and promote carbohydrate consumption.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood glucose; Metabolism; Perfluorooctanoic acid; Toxicity

Mesh:

Substances:

Year:  2017        PMID: 28947262     DOI: 10.1016/j.taap.2017.09.019

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

1.  Metabolomics of childhood exposure to perfluoroalkyl substances: a cross-sectional study.

Authors:  Samantha L Kingsley; Douglas I Walker; Antonia M Calafat; Aimin Chen; George D Papandonatos; Yingying Xu; Dean P Jones; Bruce P Lanphear; Kurt D Pennell; Joseph M Braun
Journal:  Metabolomics       Date:  2019-06-21       Impact factor: 4.290

2.  Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.

Authors:  Andres Cardenas; Marie-France Hivert; Diane R Gold; Russ Hauser; Ken P Kleinman; Pi-I D Lin; Abby F Fleisch; Antonia M Calafat; Xiaoyun Ye; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Diabetes Care       Date:  2019-07-11       Impact factor: 19.112

3.  In Vitro Assays to Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic β-Cell Model.

Authors:  Reinaldo Sousa Dos Santos; Regla María Medina-Gali; Ignacio Babiloni-Chust; Laura Marroqui; Angel Nadal
Journal:  Int J Mol Sci       Date:  2022-05-01       Impact factor: 6.208

4.  Systemic toxicity induced by topical application of heptafluorobutyric acid (PFBA) in a murine model.

Authors:  Lisa M Weatherly; Hillary L Shane; Ewa Lukomska; Rachel Baur; Stacey E Anderson
Journal:  Food Chem Toxicol       Date:  2021-08-30       Impact factor: 5.572

Review 5.  Associations between Exposures to Perfluoroalkyl Substances and Diabetes, Hyperglycemia, or Insulin Resistance: A Scoping Review.

Authors:  Rachel Margolis; Karilyn E Sant
Journal:  J Xenobiot       Date:  2021-09-14

6.  Determination of Perflourooctanoic Acid Toxicity in a Human Hepatocarcinoma Cell Line.

Authors:  Mahmoud Abudayyak; Ezgi Öztaş; Gül Özhan
Journal:  J Health Pollut       Date:  2021-08-17

7.  Exposure to Perfluoro-Octanoic Acid Associated With Upstream Uncoupling of the Insulin Signaling in Human Hepatocyte Cell Line.

Authors:  Luca De Toni; Andrea Di Nisio; Maria Santa Rocca; Diego Guidolin; Alice Della Marina; Loris Bertazza; Stefania Sut; Edoardo Purpura; Micaela Pannella; Andrea Garolla; Carlo Foresta
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-03       Impact factor: 5.555

Review 8.  Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk.

Authors:  Katherine Roth; Michael C Petriello
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

Review 9.  Persistent organic pollutants and β-cell toxicity: a comprehensive review.

Authors:  Myriam P Hoyeck; Geronimo Matteo; Erin M MacFarlane; Ineli Perera; Jennifer E Bruin
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-02-14       Impact factor: 5.900

10.  Protracted Impairment of Maternal Metabolic Health in Mouse Dams Following Pregnancy Exposure to a Mixture of Low Dose Endocrine-Disrupting Chemicals, a Pilot Study.

Authors:  Alyssa K Merrill; Timothy Anderson; Katherine Conrad; Elena Marvin; Tamarra James-Todd; Deborah A Cory-Slechta; Marissa Sobolewski
Journal:  Toxics       Date:  2021-12-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.